Clinical trial
EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic…
NCT00339118 · Sheba Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00339118 |
|---|---|
| Title | EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children |
| Lead sponsor | Sheba Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rhabdomyosarcoma |
| Intervention type | Drug |
| Interventions | doxorubicin, cytoxan |
| First posted | Jun 20, 2006 |
| Last update posted | Jun 20, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: